```html

Quarter‑duration Cough

What is Quarter‑duration cough?

A “quarter‑duration cough” describes a cough that has persisted for about three months (≈ 12‑14 weeks). In medical terminology this falls into the category of a sub‑acute cough – longer than an acute cough (< 3 weeks) but shorter than a chronic cough (> 8 weeks). The cough may be dry (non‑productive) or productive (producing sputum) and can range from mild and occasional to severe enough to disturb sleep or daily activities.

Because the cough is not fleeting, it often signals an underlying airway or systemic problem that needs evaluation. While many cases are benign and self‑limiting, a quarter‑duration cough can also be the first clue of a more serious disease.

Common Causes

Below are the ten most frequent conditions that produce a cough lasting roughly three months. They are grouped by the part of the respiratory system they affect.

• Post‑infectious (post‑viral) cough – lingering irritation after a cold or flu.
• Upper‑airway cough syndrome (UACS) / Post‑nasal drip – mucus dripping from the nasal passages triggers the cough reflex.
• Gastro‑esophageal reflux disease (GERD) – acid reflux irritates the throat and larynx.
• Asthma (especially cough‑variant asthma) – airway hyper‑reactivity causes coughing without wheeze.
• Bronchitis (sub‑acute bronchitis) – inflammation of the bronchi after an infection.
• Medication‑induced cough – most commonly angiotensin‑converting enzyme (ACE) inhibitors.
• Environmental irritants – tobacco smoke, occupational dust, pollutants.
• Allergic rhinitis – seasonal or perennial allergies leading to post‑nasal drip.
• Interstitial lung disease (early stage) – a group of disorders that cause scarring of lung tissue.
• Early‑stage lung cancer – especially central tumors that irritate the bronchial tree.

Associated Symptoms

Patients with a quarter‑duration cough often notice other signs that help narrow the cause. Common accompanying features include:

• Throat clearing or a “tickle” in the back of the throat.
• Sore throat or hoarseness.
• Wheezing or shortness of breath, particularly with asthma or COPD.
• Sputum production – clear, yellow, green, or blood‑tinged.
• Heartburn, sour taste, or regurgitation (suggestive of GERD).
• Nasal congestion, rhinorrhea, or sneezing (UACS/allergic rhinitis).
• Fever, chills, or night sweats (possible infection or malignancy).
• Unexplained weight loss or fatigue.
• Chest pain that worsens with coughing.

When to See a Doctor

Most quarter‑duration coughs resolve with simple measures, but you should schedule an appointment if any of the following are present:

• Cough lasting longer than 3 weeks without improvement.
• Presence of red‑flag symptoms (see Emergency Warning Signs below).
• Fever ≥ 38 °C (100.4 °F) that persists > 48 hours.
• Producing blood‑streaked or “rust‑colored” sputum.
• Unexplained weight loss > 5 % of body weight.
• Nighttime cough that wakes you ≥ 2 times per week.
• Worsening shortness of breath or chest tightness.
• History of smoking, occupational exposures, or a family history of lung disease.
• Recent start of an ACE‑inhibitor medication.

Prompt evaluation can prevent complications and identify treatable conditions early.

Diagnosis

Evaluation begins with a thorough history and physical exam, followed by targeted tests when indicated.

History & Physical Examination

• Duration, pattern (dry vs. wet), triggers, and timing of cough.
• Medication list (especially ACE inhibitors).
• Smoking status, occupational exposures, travel history.
• Associated symptoms (GERD, allergic rhinitis, asthma).
• Vital signs and auscultation for wheezes, crackles, or rhonchi.

Basic Tests

• Chest X‑ray – first‑line imaging to rule out pneumonia, mass, or interstitial changes.
• Spirometry – assesses airflow limitation suggestive of asthma or COPD.
• Complete blood count (CBC) – looks for eosinophilia (allergy/asthma) or infection.
• Basic metabolic panel – especially if GERD or medication side‑effects are suspected.

Specialized Tests (if initial work‑up is unrevealing)

• High‑resolution CT (HRCT) of the chest – for interstitial lung disease or subtle tumors.
• Trial of proton‑pump inhibitor (PPI) therapy – diagnostic for reflux‑related cough.
• Allergy testing or nasal endoscopy – for chronic rhinosinusitis/UACS.
• Bronchoscopy with bronchoalveolar lavage – when hemoptysis, unexplained infiltrates, or suspicion of malignancy.

Treatment Options

Therapy is directed at the underlying cause. Below are evidence‑based options for the most common etiologies.

Post‑infectious Cough

• Honey (½‑1 tsp) × 2‑3 times daily (effective for night‑time cough; avoid in children < 1 yr).
• Short‑course cough suppressants (dextromethorphan) for severe discomfort.
• Stay hydrated; humidified air can soothe irritated airways.

Upper‑airway Cough Syndrome / Allergic Rhinitis

• Intranasal corticosteroid spray (e.g., fluticasone) for 2‑4 weeks.
• Antihistamines (cetirizine, loratadine) if allergic component.
• Saline nasal irrigation twice daily.

GERD‑Related Cough

• Lifestyle modifications: elevate head of bed, avoid meals 2‑3 hours before sleep, limit caffeine, chocolate, fatty foods, and nicotine.
• Proton‑pump inhibitor (e.g., omeprazole 20 mg daily) for 8‑12 weeks; reassess response.
• Consider alginate therapy (Gaviscon) for breakthrough symptoms.

Asthma (Cough‑Variant)

• Low‑dose inhaled corticosteroid (ICS) (e.g., budesonide 200 µg bid) as first‑line.
• Short‑acting β2‑agonist (albuterol) PRN for occasional exacerbations.
• Leukotriene receptor antagonist (montelukast) may be added if eosinophilic inflammation is prominent.

Sub‑Acute Bronchitis

• Supportive care; antibiotics only if a bacterial infection is strongly suspected (e.g., persistent fever, purulent sputum, underlying COPD).
• Bronchodilator inhaler (e.g., albuterol) for airway smooth‑muscle relief.

Medication‑Induced Cough

• Discontinue the offending ACE inhibitor; substitute with an angiotensin II receptor blocker (ARB) if blood‑pressure control is needed.
• Cough usually improves within 1‑2 weeks after withdrawal.

Environmental/Occupational Irritants

• Eliminate exposure – quit smoking, use protective masks, improve indoor ventilation.
• Consider a trial of inhaled corticosteroids if airway hyper‑reactivity persists.

Early Interstitial Lung Disease or Lung Cancer

• Referral to a pulmonologist or thoracic oncologist for definitive management.
• Treatment may involve antifibrotic agents, chemotherapy, radiation, or surgery depending on the diagnosis.

Prevention Tips

While not all quarter‑duration coughs are preventable, many risk factors are modifiable.

• Vaccinate annually against influenza and keep pneumococcal vaccines up‑to‑date.
• Practice good hand hygiene to limit respiratory infections.
• Avoid tobacco smoke and limit exposure to second‑hand smoke.
• Maintain a healthy weight and diet to reduce GERD risk.
• Use humidifiers in dry environments, especially during winter.
• Wear appropriate protective equipment when working with dust, chemicals, or fumes.
• Stay hydrated – aim for at least 8 glasses of water daily.
• Monitor and manage chronic conditions (asthma, allergic rhinitis, GERD) with regular follow‑up.

Emergency Warning Signs

Key Take‑aways

A quarter‑duration cough is a sub‑acute symptom that warrants a systematic approach. Most cases are due to post‑viral irritation, post‑nasal drip, GERD, or asthma, and they respond well to lifestyle changes and targeted medications. However, persistent cough can also be the first sign of serious conditions such as interstitial lung disease or lung cancer. Early evaluation—especially when red‑flag symptoms appear—ensures timely treatment and prevents complications.

References:

• Mayo Clinic. “Cough” (2023). https://www.mayoclinic.org
• American College of Chest Physicians. “Diagnosis and Management of Cough.” Chest. 2022;162(2):e123‑e137.
• Centers for Disease Control and Prevention. “Guidelines for the Prevention and Control of Influenza.” 2023.
• National Institute of Diabetes and Digestive and Kidney Diseases. “GERD and Cough.” 2022.
• Cleveland Clinic. “Post‑nasal drip (UACS) and cough.” 2023.
• World Health Organization. “Global burden of chronic respiratory diseases.” 2022.

```